γδ T cells modulate anti-tumor immunity in small cell lung cancer
Jin Ng, Yue You, Tina Z. Zhang, Jonas B. Hess et autres
Small cell lung cancer (SCLC) is a highly aggressive neoplasm with limited sensitivity to anti-PD-(L)1 blockade, which is likely caused by the epigenetic silencing of MHC-I. Elucidating MHC-I-independent immune recognition mechanisms is therefore crucial for enhancing treatment responses and improving clinical outcomes …
au, de, se, us, gb (code pays fourni par la source)
0 citations
Cancer Cell